Evidence map›Paper›PMID 42729813›Full record

ArticleFrontiers in pediatrics2026

Correction: Potential role of pyridostigmine in the management of pediatric chronic intestinal pseudo-obstruction in a girl with ACTL6B mutation: a case report and a review of literature.

Immacolata Rulli, Angelo Mattia Carcione, Claudio Romano, Roberto Chimenz, Valeria Chirico, Lucia Marseglia, Carmelo Romeo, Eloisa Gitto

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Immacolata Rulli *Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Angelo Mattia Carcione *Neonatal and Pediatric Intensive Care Unit, Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Claudio RomanoPediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Roberto ChimenzPediatric Nephrology and Dialysis Unit, Department of Human Pathology of Adult and Childhood "Gaetano Barresi", University of Messina, Messina, Italy.
Valeria ChiricoPediatric Nephrology and Dialysis Unit, Department of Human Pathology of Adult and Childhood "Gaetano Barresi", University of Messina, Messina, Italy.
Lucia MarsegliaNeonatal and Pediatric Intensive Care Unit, Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Carmelo RomeoPediatric Surgery Unit, Department of Human Pathology of Adult and Childhood "Gaetano Barresi", University of Messina, Messina, Italy.
Eloisa GittoNeonatal and Pediatric Intensive Care Unit, Department of Human Pathology of Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fped.2026.1761705.].

Indexed as

ACTL6B mutationefficacyPIPOpyridostigminesafety

Identifiers

PMID42729813
PMCPMC13563043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.